Skip to main content
Premium Trial:

Request an Annual Quote

Massive Bio's Oncology Genomics Advisory Service

Massive Bio has launched an on-demand genomic advisory service for community oncologists. Through the service, the company is offering oncologists assistance with genomic-based test selection and new treatment options after standard approaches like chemotherapy fail.  The company is discussing the service at the annual American Society of Clinical Oncology being held in Chicago.

In addition the service, Massive Bio also plans to offer a subscription-based enterprise solution that will be integrated with oncology practices' electronic health record systems.  The solution will enable the company's advisory services to be used on a larger scale and in a more automated way. The soultion will be available in early Q3 of this year.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.